Regarding the pathogenesis of ICI colitis, the systemic mechanism underlying the onset of adverse events is related to CTLA4 expression by regulatory T cells (Treg), and to the binding of CD28 and CD80/86 (on the T cell surface and antigen-presenting cell surface, respectively), an activating signal for T cells. The gene discussed is CTLA4; the disease is colitis.